HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Systematic Electrophysiological Study Prior to Pulmonary Valve Replacement in Tetralogy of Fallot: A Prospective Multicenter Study.

AbstractBACKGROUND:
Ventricular arrhythmias and sudden death are recognized complications in tetralogy of Fallot. Electrophysiological studies (EPS) before pulmonary valve replacement (PVR), the most common reintervention in tetralogy of Fallot, could potentially inform therapy to improve arrhythmic outcomes.
METHODS:
A prospective multicenter study was conducted to systematically assess EPS with programmed ventricular stimulation in patients with tetralogy of Fallot referred for PVR from January 2020 to December 2021. A standardized stimulation protocol was used across all centers.
RESULTS:
A total of 120 patients were enrolled, mean age 39.2±14.5 years, 53.3% males. Sustained ventricular tachycardia was induced in 27 (22.5%) patients. When identifiable, the critical isthmus most commonly implicated (ie, in 90.0%) was between the ventricular septal defect patch and pulmonary annulus. Factors independently associated with inducible ventricular tachycardia were history of atrial arrhythmia (odds ratio, 8.56 [95% CI, 2.43-34.73]) and pulmonary annulus diameter >26 mm (odds ratio, 5.05 [95% CI, 1.47-21.69]). The EPS led to a substantial change in management in 23 (19.2%) cases: 18 (15.0%) had catheter ablation, 3 (2.5%) surgical cryoablation during PVR, and 9 (7.5%) defibrillator implantation. Repeat EPS 5.1 (4.8-6.2) months after PVR was negative in 8 of 9 (88.9%) patients. No patient experienced a sustained ventricular arrhythmia during 13 (6.1-20.1) months of follow-up.
CONCLUSIONS:
Systematically performing programmed ventricular stimulation in patients with tetralogy of Fallot referred for PVR yields a high rate of inducible ventricular tachycardia and carries the potential to alter management. It remains to be determined whether a standardized treatment approach based on the results of EPS will translate into improved outcomes.
REGISTRATION:
URL: https://clinicaltrials.gov/ct2/show/NCT04205461; Unique identifier: NCT04205461.
AuthorsVictor Waldmann, Francis Bessière, Kevin Gardey, Mohamed Bakloul, Emre Belli, Damien Bonnet, Anne-Solène Chaussade, Sarah Cohen, Hubert Delasnerie, Nabil Dib, Sylvie Di Filippo, Arnaud Dulac, Sébastien Hascoët, Roland Henaine, Laurence Iserin, Clément Karsenty, Magalie Ladouceur, Antoine Legendre, Sophie Malekzadeh-Milani, Mansour Mostefa Kara, Jelena Radojevic, Miarisoa Ratsimandresy, Eloi Marijon, Alice Maltret, Paul Khairy, Nicolas Combes
JournalCirculation. Arrhythmia and electrophysiology (Circ Arrhythm Electrophysiol) Vol. 16 Issue 6 Pg. e011745 (06 2023) ISSN: 1941-3084 [Electronic] United States
PMID37170812 (Publication Type: Multicenter Study, Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Male
  • Humans
  • Young Adult
  • Adult
  • Middle Aged
  • Female
  • Pulmonary Valve (surgery)
  • Tetralogy of Fallot (surgery)
  • Heart Valve Prosthesis Implantation (adverse effects)
  • Prospective Studies
  • Treatment Outcome
  • Tachycardia, Ventricular (diagnosis, etiology, surgery)
  • Arrhythmias, Cardiac
  • Pulmonary Valve Insufficiency (etiology, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: